We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$43.7M
Cap. Flow
+$33.5M
Cap. Flow %
16.82%
Top 10 Hldgs %
59.34%
Holding
42
New
12
Increased
12
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$6.24M
2
IBB icon
iShares Biotechnology ETF
IBB
+$4.43M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.26M
4
FND icon
Floor & Decor
FND
+$1.97M
5
MCK icon
McKesson
MCK
+$1.82M

Top Sells

Rank Stock Value
1
LVLT
Level 3 Communications Inc
LVLT
+$602K
2
TMO icon
Thermo Fisher Scientific
TMO
+$185K
3
CVS icon
CVS Health
CVS
+$130K
4
HCA icon
HCA Healthcare
HCA
+$118K
5
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$83.8K

Sector Composition

Rank Sector Weight
1 Industrials 37.17%
2 Healthcare 23.07%
3 Consumer Discretionary 12.56%
4 Financials 8.6%
5 Miscellaneous 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDG icon
1
TransDigm Group
TDG
$65.6B
$22.6M 11.36%
84,061
+24,599
+41% +$6.24M
UAL icon
2
United Airlines
UAL
$36.5B
$18.9M 9.5%
251,200
+10,000
+4% +$755K
LVLT
3
DELISTED
Level 3 Communications Inc
LVLT
$18.9M 9.49%
318,417
-10,000
-3% -$602K
DAL icon
4
Delta Air Lines
DAL
$53.4B
$11.2M 5.64%
208,710
– –
MHK icon
5
Mohawk Industries
MHK
$8.79B
$9.67M 4.86%
40,000
– –
CNC icon
6
Centene
CNC
$32.3B
$9.2M 4.63%
230,400
– –
HCA icon
7
HCA Healthcare
HCA
$90.8B
$7.5M 3.77%
85,970
-1,400
-2% -$118K
GS icon
8
Goldman Sachs
GS
$303B
$6.73M 3.38%
30,340
+6,000
+25% +$1.33M
EXPE icon
9
Expedia Group
EXPE
$38.3B
$6.7M 3.37%
45,000
– –
XRAY icon
10
Dentsply Sirona
XRAY
$2.2B
$6.65M 3.34%
102,606
– –
ESRX
11
DELISTED
Express Scripts Holding Company
ESRX
$5.98M 3.01%
93,726
+14,500
+18% +$911K
CVS icon
12
CVS Health
CVS
$119B
$5.69M 2.86%
70,704
-1,650
-2% -$130K
VSM
13
DELISTED
Versum Materials, Inc.
VSM
$5.26M 2.65%
162,000
– –
ZAYO
14
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$5.1M 2.56%
165,000
+40,000
+32% +$1.31M
AMZN icon
15
Amazon
AMZN
$2.76T
$4.84M 2.43%
100,000
– –
IBB icon
16
iShares Biotechnology ETF
IBB
$10.8B
$4.65M 2.34%
+45,000
New +$4.43M
XBI icon
17
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$4.63M 2.33%
+60,000
New +$4.26M
LAZ icon
18
Lazard
LAZ
$4.21B
$3.84M 1.93%
82,911
+10,000
+14% +$448K
CBPO
19
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$3.76M 1.89%
33,251
-750
-2% -$83.8K
SF
20
Stifel
SF
$12.2B
$3.43M 1.72%
167,625
+22,500
+16% +$462K
MCK icon
21
McKesson
MCK
$104B
$3.29M 1.65%
20,000
+12,000
+150% +$1.82M
XOP icon
22
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.77B
$3.19M 1.6%
25,000
– –
GLD icon
23
SPDR Gold Trust
GLD
$154B
$2.93M 1.47%
24,850
+5,000
+25% +$598K
ST icon
24
Sensata Technologies
ST
$6.18B
$2.48M 1.25%
58,160
– –
CCMP
25
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2M 1.01%
27,118
– –
1
2

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q2 2017 Portfolio in Review

As of Q2 2017, Errol M. Rudman held 42 positions worth $199M, up 28% from $155M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Errol M. Rudman deployed $33.5M of net new capital in Q2 2017, opening 12 new positions and adding to 12 existing holdings. Its largest new stake was iShares Biotechnology ETF: 45,000 shares worth $4.65M.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Level 3 Communications Inc, an estimated $602K trimmed.

  • Errol M. Rudman's largest Q2 2017 buy was iShares Biotechnology ETF: 45,000 shares worth $4.65M.
  • Errol M. Rudman added most to TransDigm Group in Q2 2017, an estimated $6.24M increase.
  • Errol M. Rudman's biggest Q2 2017 reduction was Level 3 Communications Inc, cutting an estimated $602K.
  • Errol M. Rudman's ten largest holdings make up 59% of its $199M portfolio in Q2 2017.
  • Errol M. Rudman opened 12 new positions and closed 0 in Q2 2017.
  • Errol M. Rudman's portfolio value rose 28% quarter-over-quarter to $199M.

Based on Errol M. Rudman's 13F filing for Q2 2017, filed 14 Aug 2017.